Condition
Terlipressin Adverse Reaction
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Unknown2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04221672Phase 3UnknownPrimary
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04028505Phase 3UnknownPrimary
Terlipressin Infusion in Variceal Hemorrhage
NCT03395574Phase 2CompletedPrimary
Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation
Showing all 3 trials